We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Industry Insights

Development of Immunotherapy To Treat COVID-19 in Progress
Industry Insight

CEL-SCI Corporation recently announced that it is utilizing LEAPS peptide technology in efforts to develop an immunotherapy against the novel coronavirus caused by SARS-CoV-2. Technology Networks, spoke with Daniel Zimmerman, Ph.D. Senior VP of Research, Cellular Immunology at CEL-SCI Corporation, to learn more about the LEAPS technology.

Read More

Targeting the Vaginal Microbiome for Urogenital and Reproductive Health
Industry Insight

Technology Networks recently spoke with Dr Jacques Ravel (Chief Scientist of LUCA Biologics) and Luba Greenwood (CEO of LUCA Biologics) to learn more about what the vaginal microbiome is, how it can contribute to human pathology and the development of novel therapeutics in this space that are approaching clinical trials.

Read More

Removing the Barriers to Broad Adoption of NGS in Diagnostics
Industry Insight

What barriers still exist to the full implementation of next-generation sequencing (NGS) in the diagnostics space, and how can we remove them? Technology Networks recently spoke with Luca Quagliata, Ph.D., Global Director of Medical Affairs for Thermo Fisher Scientific, to learn more.

Read More

Facilitating Cell Culture Growth and Protecting Protein Integrity
Industry Insight

Many biotherapeutic drugs such as recombinant antibodies are manufactured utilizing host cells, a common example being Chinese hamster ovary (CHO) cells. A key factor for consideration in this process is the growth and viability of these cells – ultimately this influences the quality and quantity of the biotherapeutic product. Technology Networks spoke with Nicole Wellens, Global Product Manager for BioTherapeutics Media, Lonza to learn more about the new feed and how it has been developed.

Read More

Reducing Errors in Whole Genome Sequencing: It Starts With Library Prep
Industry Insight

The highly complex process of whole genome sequencing comes with a high cost of error. One pipetting or mixing mistake can lead to costly errors downstream. When working with multiple samples, error-free sample handling and proper mixing becomes even more critical. The first step in the process to prepare the sample for sequencing, library prep, is a vital step that, if not done correctly, can lead to flawed data and costly delays.

Read More

An Online Educational Resource for Cell Scientists
Industry Insight

Introduced back in March 2019, Cell MentorTM is an online educational resource for biology students and researchers, created by Cell Signaling Technology and Cell Press. To open the resource up to even more scientists, a Chinese version of the site was recently launched.

Read More

Detecting Sepsis Early
Industry Insight

We recently spoke to Elena Sukhacheva, Director Medical and Scientific Affairs at Beckman Coulter, to learn about some of the challenges of diagnosing sepsis early, and how measuring Monocyte Distribution Width can be used as a sepsis biomarker to aid the process.

Read More

Looking Back on Gene Editing Advances in 2019 and Towards What the Future May Hold
Industry Insight

With constant conversations examining the potential of CRISPR technology, it can be hard to focus on what has been achieved since 2012 and to look toward the future to determine what may be achievable both in the near – and longer – term.

Read More

Exploring the Potential of Protein Degradation-focused Drug Discovery
Industry Insight

Ubiquigent's Jason Brown and Jason Mundin discuss the role of the ubiquitin cascade in cellular signaling and explain how it can be exploited to support protein degradation-focused drug discovery.

Read More

Harnessing Gamma T Cells To Bring Effective Therapies to Patients
Industry Insight

Technology Networks recently spoke with Natalie Mount, CEO of Adaptate BioTherapeutics, to learn more about the company's aims and the challenges faced when developing immunotherapies and advancing them into clinical studies.

Read More

 
Advertisement